Educational Video The Path to Approval

Physician Groups Comment on Biosimilar Reimbursement: Urge CMS to Adopt Unique Billing Codes

Updated Handbook The Biosimilar Promise: An Introduction for Prescribers

ASH Annual Meeting & Exposition

BPC Statement Applauding FDA for Distinguishable Biologics Naming; Disappointed in ‘Random’ Suffix

About the Biologics Prescribers Collaborative

The Biologics Prescribers Collaborative aims to ensure that sound policies are in place to promote the safest possible use of all biologics, including biosimilars, for all patients.

Learn More About Us

Member Organizations

Physician Co-conveners

Dennis R. Cryer, MD

Dennis R. Cryer, MD

Genetics and Metabolism, Washington, DC

Gregory Schimizzi, MD

Gregory Schimizzi, MD

Rheumatology, Wilmington, NC

David Charles, MD

David Charles, MD

AfPA National Chairman Neurology, Nashville, TN